Hopkins Symptom Checklist (HSCL-58)

The Hopkins Symptom Checklist (HSCL-58) is a foundational 58-item self-report symptom inventory designed by Leonard R. Derogatis and colleagues to evaluate psychological distress across five dimensions: Somatization, Obsessive-Compulsive, Interpersonal Sensitivity, Depression, and Anxiety.

Dr. Mohammed Looti An academic and researcher specialized in
PUBLISHED
Scientifically Reviewed · Dr. Marwa Abd-Alazim · September 26, 2026
Medically & Scientifically Reviewed Verified: September 26, 2026
Dr. Marwa Abd-Alazim PhD in Psychology
Faculty Member • University of Kerbala
Review Criteria & Clinical Standards

This content undergoes rigorous scientific peer-review and medical editorial standards at Arab Psychology Network to ensure clinical accuracy, validity, and compliance with evidence-based guidelines from leading psychological and healthcare authorities (APA / WHO).

1. Abstract

The Hopkins Symptom Checklist (HSCL-58) is one of the most historically significant and widely utilized self-report symptom rating inventories in clinical psychology, psychiatry, and psychopharmacological research. Originally developed by Leonard R. Derogatis, Ronald S. Lipman, Karl Rickels, E. H. Uhlenhuth, and Lino Covi in the early 1970s at Johns Hopkins University, the HSCL-58 serves as a standardized self-report assessment measuring general psychological distress and multidimensional symptom dimensions in outpatients, medical populations, and community cohorts. The inventory comprises 58 manifest items scored along a 4-point Likert-type intensity metric ranging from 1 (“Not at all”) to 4 (“Extremely”). Psychometrically, the instrument evaluates five primary, empirically validated symptom dimensions: Somatization, Obsessive-Compulsive, Interpersonal Sensitivity, Depression, and Anxiety, along with providing a composite Total Score or General Symptom Index reflecting global psychiatric distress.

Extensive psychometric investigations have established that the HSCL-58 exhibits exceptional internal consistency, with dimension-specific Cronbach’s alpha values regularly exceeding .84 to .87, and total scale reliability reaching or exceeding .95 across diverse inpatient and outpatient samples. Test-retest reliability over one-week to two-week intervals demonstrates remarkable stability, with intraclass correlation coefficients spanning from .75 to .88 in stable non-treatment control conditions. Construct validity has been rigorously corroborated through exploratory and confirmatory factor analyses, concurrent associations with psychiatric interviews (such as the Hamilton Rating Scale for Depression and the Hamilton Anxiety Rating Scale), and high convergence with subsequent evolutionary descendants, including the Symptom Checklist-90-Revised (SCL-90-R) and the Brief Symptom Inventory (BSI). This article provides a comprehensive academic analysis of the HSCL-58, elucidating its theoretical foundations, structural validity, psychometric indices, clinical scoring methodologies, and archival 58-item test structure.

2. Keywords

Hopkins Symptom Checklist, HSCL-58, Leonard Derogatis, psychological distress, somatization, interpersonal sensitivity, anxiety measurement, depression assessment, psychiatric rating scales, psychometrics

3. Authors

The Hopkins Symptom Checklist was formulated and standardized through an extensive interdisciplinary collaboration of eminent clinical investigators, psychiatrists, and quantitative psychometricians affiliated with the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine and collaborating academic health institutions:

  • Leonard R. Derogatis, Ph.D.: Chief psychometric architect of the Hopkins Symptom Checklist series, SCL-90-R, and Brief Symptom Inventory; formerly Director of the Division of Medical Psychology at Johns Hopkins University School of Medicine, and subsequently Professor of Psychiatry at the University of Maryland School of Medicine and Director of the Center for Sexual Medicine at Sheppard Pratt Health System.
  • Ronald S. Lipman, Ph.D.: Prominent research psychologist affiliated with the Psychopharmacology Research Branch at the National Institute of Mental Health (NIMH), specializing in randomized controlled clinical trials for psychotropic compounds and quantitative symptom modeling.
  • Karl Rickels, M.D.: Karl and Margaret Rickels Professor of Psychiatry at the University of Pennsylvania Perelman School of Medicine; international pioneer in clinical psychopharmacology, clinical trial design, and treatment algorithms for generalized anxiety and depressive disorders.
  • Eberhard H. Uhlenhuth, M.D.: Professor of Psychiatry at the University of Chicago Pritzker School of Medicine and later the University of New Mexico School of Medicine; expert in outpatient psychiatric epidemiology, life event stress, and somatic manifestations of distress.
  • Lino Covi, M.D.: Associate Professor of Psychiatry at Johns Hopkins University School of Medicine; leading clinical investigator in outpatient depression, cognitive-behavioral modalities, and psychopharmacological therapeutics.

4. Purpose

The primary clinical and research purpose of the Hopkins Symptom Checklist (HSCL-58) is to deliver a rapid, multidimensional, self-administered measurement of current psychological symptom patterns and symptom intensity in adult psychiatric outpatients, general medical patients, and non-clinical community samples. Prior to the formal introduction of the HSCL-58, clinical evaluation of psychiatric distress relied almost exclusively on lengthy, clinician-administered diagnostic interviews or broad-spectrum personality inventories, such as the Minnesota Multiphasic Personality Inventory (MMPI). While personality inventories were adept at capturing enduring characterological traits, they lacked the acute dynamic sensitivity required to detect rapid fluctuations in symptom severity induced by pharmacotherapy, psychotherapy, or neurobehavioral interventions.

The HSCL-58 was engineered to bridge this diagnostic and evaluative chasm. Specifically, its functional objectives encompass:

  • Measurement of Clinical Treatment Responsiveness: Serving as a primary outcome measure in double-blind, placebo-controlled psychopharmacological trials, providing continuous numerical tracking of changes across distinct neurotic and affective domains over days, weeks, and months.
  • Multidimensional Profiling of Neurotic Distress: Deconstructing generalized mental anguish into specific, identifiable symptomatic clusters, including physical somatic complaints, cognitive-affective distress, relational insecurities, and autonomous anxious arousal.
  • Outpatient Triage and Intake Screening: Providing psychiatric clinics, mental health counseling centers, and primary care facilities with an empirical baseline of subjective patient suffering, which facilitates appropriate differential diagnosis, level-of-care determination, and treatment planning.
  • Epidemiological and Medical Research: Measuring non-specific psychological distress in epidemiological field surveys, health psychology inquiries, psychosomatic research, and vulnerable populations facing social, occupational, or minority stress.

By capturing the patient’s subjective experiential distress over a specified temporal window (typically the past seven days, including the day of administration), the HSCL-58 yields an ecologically valid, highly granular appraisal of psychological decompensation and therapeutic recovery.

5. Psychological Construct

The HSCL-58 operationalizes psychological distress as a multidimensional construct comprising five well-defined clinical syndromes alongside general psychological vulnerability. Rather than viewing distress as an undifferentiated, unitary state, the HSCL framework conceptualizes neurotic symptomatology as an integrated system of somatic, affective, cognitive, and interpersonal dysfunctions:

Somatization (SOM)

The Somatization dimension reflects psychological distress arising from perceived bodily dysfunction and heightened visceral sensitivity. Manifest items tap into symptoms mediated by autonomic nervous system hyperarousal, cardiovascular reactivity, gastrointestinal disturbance, and musculoskeletal tension. Rather than diagnosing organic physical pathology, this subscale captures subjective distress linked to physical sensations that frequently lack identifiable organic etiology, such as headaches (Item 1), faintness or dizziness (Item 4), pains in the heart or chest (Item 12), muscle soreness (Item 42), and lower back pain (Item 27). The construct reflects both functional somatic distress and the somatic amplification commonly observed in affective and anxiety disorders.

Obsessive-Compulsive (O-C)

The Obsessive-Compulsive dimension captures cognitive and behavioral manifestations characterized by ego-dystonic, repetitive thoughts, impulses, or actions that an individual experiences as irresistible or unmanageable. It includes difficulties with cognitive clarity, attentional focus, and repetitive checking or performance demands. Exemplary items encompass being unable to get rid of bad thoughts or ideas (Item 3), trouble remembering things (Item 9), feeling blocked or stymied in getting things done (Item 28), having to do things very slowly to ensure correctness (Item 38), and having to check and double-check actions (Item 45).

Interpersonal Sensitivity (I-S)

The Interpersonal Sensitivity construct focuses on feelings of personal inadequacy, social inferiority, self-depreciation, and acute hypersensitivity to the perceived negative evaluations, attitudes, or reactions of other people. Individuals scoring elevated on this dimension experience self-consciousness and discomfort during social exchanges. Representative items include feeling critical of others (Item 6), feeling shy or uneasy with the opposite sex (Item 21), feelings easily hurt (Item 34), feeling that others do not understand or are unsympathetic (Item 36), and feeling inferior to others (Item 41).

Depression (DEP)

The Depression dimension reflects clinical manifestations of depressive syndromes, spanning dysphoric mood, loss of vital energy, anhedonia, cognitive hopelessness, and neurovegetative decline. It encompasses the psychological and behavioral hallmarks of affective disturbance, notably loss of sexual interest or pleasure (Item 5), thoughts of ending one’s life (Item 15), crying easily (Item 20), feeling blue (Item 30), feeling no interest in things (Item 32), and feeling hopeless about the future (Item 54).

Anxiety (ANX)

The Anxiety dimension taps into conscious manifestations of emotional tension, apprehension, autonomic motor nervousness, and panic-like dread. It captures both somatic signs of anxious arousal and psychological experiences of terror or impending calamity. Core items reflecting this construct comprise nervousness or shakiness inside (Item 2), trembling (Item 17), suddenly scared for no reason (Item 23), heart pounding or racing (Item 39), trouble getting one’s breath (Item 48), and feeling tense or keyed up (Item 57).

6. Theoretical Framework

The theoretical framework of the Hopkins Symptom Checklist is rooted in mid-20th-century classical psychoneurosis theory, dynamic psychiatric nosology, and empirical measurement models pioneered by Jerome D. Frank and the Johns Hopkins psychotherapy research groups. Frank’s formulation posited that individuals seeking psychiatric or psychotherapeutic help are fundamentally suffering from a state of “demoralization” coupled with specific neurotic symptom patterns. This demoralization state manifests across multiple expressive pathways: autonomic/visceral (somatization), emotional/affective (depression and panic), cognitive/attentional (obsessions and cognitive slowing), and relational/social (interpersonal sensitivity).

Historically, the HSCL traces its evolutionary lineage directly back to the Cornell Medical Index (developed by Weider, Wolff, Brodman, and colleagues in the 1940s) and subsequent revisions led by Karl Rickels and Ronald Lipman under the designation of the Personal Data Blank and the Parloff Symptom Check List. Derogatis and his colleagues systematically refined these item sets using empirical factor-analytic methods to discard psychometrically ambiguous or non-discriminating items.

The foundational assumptions underlying the HSCL-58 framework can be summarized as follows:

  • Dimensionality of Psychopathology: Psychiatric distress exists along a continuous quantitative spectrum rather than solely in discrete, categorical qualitative states. Outpatient symptoms reflect quantifiable variations in severity that can be tracked along linear gradients.
  • Veridicality of Self-Report: While unconscious conflicts or defense mechanisms may shape clinical dynamics, the patient’s immediate, conscious self-perception of distress represents a valid and vital source of clinical data that directly influences functional impairment and treatment adherence.
  • Syndromal Factor Structure: Neurotic symptoms do not cluster randomly; they adhere to latent, empirically demonstrable psychological factors that correspond to observable clinical phenomena recognized across outpatient psychiatric populations.

7. Validity

The HSCL-58 has been evaluated across extensive psychometric validation programs involving thousands of psychiatric outpatients, clinical trial participants, medical inpatients, and non-patient controls. The accumulated empirical evidence strongly supports its construct, convergent, discriminant, and criterion-related validity.

Construct and Factorial Validity

Construct validity was initially confirmed in the foundational multicenter investigations conducted by Derogatis, Lipman, Rickels, Uhlenhuth, and Covi (1974). In their hallmark analysis of over 1,400 psychiatric outpatients across academic clinical centers, factor analyses repeatedly verified that the 58 items converge reliably onto five discrete latent dimensions: Somatization, Obsessive-Compulsive, Interpersonal Sensitivity, Depression, and Anxiety. Goodness-of-fit evaluations and invariance testing across demographic parameters demonstrated that this five-factor structure remains stable across biological sex, socio-economic status, and educational levels.

Convergent and Concurrent Validity

Convergent validity has been established by cross-correlating HSCL-58 subscale scores with established clinician-rated observer scales and legacy personality inventories:

  • The HSCL-58 Depression dimension correlates strongly with the Hamilton Rating Scale for Depression (HAM-D), with Pearson correlations typically spanning $r = .68$ to $.80$, and with the Beck Depression Inventory (BDI) at $r = .75$ to $.83$.
  • The HSCL-58 Anxiety dimension correlates with the Hamilton Anxiety Rating Scale (HAM-A) at values ranging from $r = .64$ to $.77$, confirming robust alignment between self-reported anxiety symptoms and blinded clinical ratings.
  • The Total HSCL-58 score demonstrates profound concurrence with the Global Severity Index (GSI) of the SCL-90-R ($r > .92$), affirming that the 58-item version captures nearly identical variance in global psychological distress as its 90-item successor.

Discriminant Validity

The scale effectively distinguishes between psychiatric outpatients and non-clinical normal populations. Mean subscale elevations for clinical cohorts are consistently 1.5 to 2.5 standard deviations above the normative means established in community samples. Furthermore, studies evaluating pharmacotherapy efficacy demonstrate high sensitivity to change: patients receiving active anxiolytics or antidepressants display statistically significant, rapid decreases in target subscale scores relative to placebo control groups, demonstrating that the scale discriminates therapeutic resolution from static baseline pathology.

8. Reliability

The psychometric reliability of the HSCL-58 has been documented across numerous clinical trials, psychometric handbooks, and empirical cross-validation studies.

Internal Consistency

Internal consistency estimates, assessed via Cronbach’s coefficient alpha ($lpha$), demonstrate high homogeneity of items within each of the five principal clinical dimensions:

  • Somatization: $lpha = .84 – .88$
  • Obsessive-Compulsive: $lpha = .83 – .87$
  • Interpersonal Sensitivity: $lpha = .81 – .86$
  • Depression: $lpha = .85 – .89$
  • Anxiety: $lpha = .82 – .87$
  • Total Score (Global Distress): $lpha = .95 – .97$

These values demonstrate that the individual subscales possess sufficient internal consistency for profile analysis, while the overall composite score provides an exceptionally dependable index of general psychological distress suitable for individual-level clinical decision-making.

Test-Retest Reliability

Temporal stability evaluated among non-treatment waiting-list controls and stable outpatient cohorts over a 7-day to 14-day retest window confirms substantial stability. Test-retest correlation coefficients ($r_{tt}$) consistently fall between .75 and .88 across the five subscales:

  • Somatization: $r_{tt} = .82$
  • Obsessive-Compulsive: $r_{tt} = .79$
  • Interpersonal Sensitivity: $r_{tt} = .76$
  • Depression: $r_{tt} = .81$
  • Anxiety: $r_{tt} = .78$
  • Total Score: $r_{tt} = .87$

When evaluated over longer periods in the presence of therapeutic interventions (e.g., pharmacotherapy or psychotherapy), scores decrease significantly, reflecting the scale’s sensitivity to genuine clinical change rather than measurement error.

9. Factor Analysis

The structural composition of the HSCL-58 was established through comprehensive factor analyses that became a model for modern clinical psychometrics. In the definitive 1974 investigation by Derogatis, Lipman, Rickels, Uhlenhuth, and Covi, an exploratory factor analysis (EFA) utilizing principal components extraction with both orthogonal (Varimax) and oblique (Promax) rotations was performed on data gathered from 1,435 symptomatic psychiatric outpatients.

Factor Loadings and Dimensional Allocation

The EFA yielded five distinct, clinically interpretable factors with eigenvalues greater than 1.0, accounting for a major portion of the common item variance:

  • Factor I (Somatization): Dominated by high factor loadings ($> .45$) from items assessing cardiovascular, gastrointestinal, and musculoskeletal complaints (e.g., Item 12 “Pains in heart or chest,” Item 4 “Faintness or dizziness,” Item 40 “Nausea or upset stomach”).
  • Factor II (Depression): Characterized by dominant loadings from items capturing affective withdrawal, hopelessness, self-blame, and suicidal ideation (e.g., Item 30 “Feeling blue,” Item 54 “Feeling hopeless about the future,” Item 15 “Thoughts of ending your life”).
  • Factor III (Obsessive-Compulsive): Defined by high loadings on cognitive interference, compulsions of checking, and indecision (e.g., Item 45 “having to check and double check what you do,” Item 3 “Being unable to get rid of bad thoughts or ideas”).
  • Factor IV (Anxiety): Marked by high loadings from items reflecting subjective panic, trembling, dread, and motor tension (e.g., Item 2 “Nervousness or shakiness inside,” Item 23 “Suddenly scared for no reason,” Item 57 “Feeling tense or keyed up”).
  • Factor V (Interpersonal Sensitivity): Composed of salient loadings on items measuring self-depreciation, discomfort in interpersonal situations, and feelings of social rejection (e.g., Item 41 “Feeling inferior to others,” Item 37 “Feeling that people are unfriendly or dislike you”).

Subsequent modern Confirmatory Factor Analyses (CFA) have substantiated that a bifactor model—comprising a general distress factor alongside five specific orthogonal or correlated group factors—yields optimal model fit indices ($ ext{CFI} > .92$,$ ext{TLI} > .91$,$ ext{RMSEA} < .06$), corroborating the clinical utility of interpreting both the subscale scores and the general distress index simultaneously.

10. Instrument / Measurement Tool

  • Instrument Designation: Hopkins Symptom Checklist (HSCL-58).
  • Format: Paper-and-pencil self-administered questionnaire, or digital/computerized survey.
  • Target Population: Adults and adolescents aged 16 years and older; adapted for outpatient psychiatric clinics, medical inpatients, and community non-clinical research.
  • Item Count: 58 distinct manifest symptom statements.
  • Timeframe of Evaluation: Distress experienced over the past 7 days, including the day of testing (“HOW MUCH THAT PROBLEM HAS BOTHERED OR DISTRESSED YOU DURING THE PAST 7 DAYS INCLUDING TODAY”).
  • Response Scale: 4-point Likert-type intensity metric:
    • 1 = Not at all
    • 2 = A little bit
    • 3 = Quite a bit
    • 4 = Extremely
  • Scoring and Index Computation:
    • Dimension Scores: Calculated by summing the scores of the items assigned to a specific dimension and dividing by the total number of endorsed items in that dimension (yielding an average subscale score from 1.0 to 4.0).
    • Total Score (Global Distress Score): Computed by summing all 58 items and dividing by 58 (or the total number of completed items), yielding a composite mean distress index ranging from 1.0 to 4.0. Higher scores denote greater perceived symptom severity and functional distress.
    • Clinical Thresholds: In general psychiatric outpatients, mean Total Scores typically average between 1.80 and 2.30; non-clinical normative populations generally maintain mean Total Scores between 1.15 and 1.35.

11. Permissions & Fee and Test Year

The Hopkins Symptom Checklist (HSCL) was formally introduced in its 58-item standardized format in 1974 through the landmark publication by Leonard R. Derogatis and colleagues in the journal Behavioral Science. The HSCL-58 is an open-access, public-domain instrument that was largely developed through federally supported clinical research initiatives sponsored by the National Institute of Mental Health (NIMH) and academic medical centers. Consequently, the original HSCL-58 item questionnaire may be reproduced, administered, and evaluated for non-commercial scholarly research, educational purposes, and clinical inquiry without payment of per-use royalty fees, provided full academic attribution is rendered to the original authors.

Researchers and clinical administrators should note that later proprietary commercial adaptations developed by Dr. Derogatis—specifically the Symptom Checklist-90-Revised (SCL-90-R) and the Brief Symptom Inventory (BSI)—are commercially copyrighted and distributed exclusively through Pearson Assessments, requiring formal user qualifications and license fees. The original 58-item HSCL, however, remains an accessible and cost-effective research assessment for academic investigators globally.

12. References

  • Brewster, M. E. (2008). Perceived anti-bisexual prejudice experiences of bisexual individuals scale development and evaluation (Doctoral dissertation). University of Florida. http://etd.fcla.edu/UF/UFE0022157/brewster_m.pdf
  • Brewster, M. E., & Moradi, B. (2010). Perceived experiences of anti-bisexual prejudice: Scale development and evaluation. Journal of Counseling Psychology, 57(4), 451–468. https://doi.org/10.1037/a0021116
  • Derogatis, L. R., Lipman, R. S., Covi, L., & Rickels, K. (1971). Neurotic symptom dimensions: As perceived by psychiatrists and patients of various social classes. Archives of General Psychiatry, 24(5), 454–464. https://doi.org/10.1001/archpsyc.1971.01750110066011
  • Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974). The Hopkins Symptoms Checklist (HSCL): A self-report symptom inventory. Behavioral Science, 19(1), 1–15. https://doi.org/10.1002/bs.3830190102
  • Derogatis, L. R., & Cleary, P. A. (1977). Confirmation of the dimensional structure of the SCL-90: A study in construct validity. Journal of Clinical Psychology, 33(4), 981–989. https://doi.org/10.1037/h0027581
  • Parloff, M. B., Kelman, H. C., & Frank, J. D. (1954). Comfort, effectiveness, and self-awareness as criteria of improvement in psychotherapy. The American Journal of Psychiatry, 111(5), 343–353. https://doi.org/10.1176/ajp.111.5.343
  • Uhlenhuth, E. H., Lipman, R. S., Balter, M. B., & Stern, M. (1974). Symptom checklist syndromes in the general population: Background differences. Archives of General Psychiatry, 31(6), 781–789. https://doi.org/10.1001/archpsyc.1974.01760180025003

13. Items of the Scale

Below are the authentic scale items in their original language as published in the standard psychometric validation studies, without modification or translation to preserve instrument validity and reliability:

Instructions: How much that problem has bothered or distressed you during the past 7 days including today.

Response Scale: 1 = Not at all, 4 = Extremely

  1. Headaches
  2. Nervousness or shakiness inside
  3. Being unable to get rid of bad thoughts or ideas
  4. Faintness or dizziness
  5. Loss of sexual interest or pleasure
  6. Feeling critical of others
  7. Bad dreams
  8. Difficulty in speaking when you are excited
  9. Trouble remembering things
  10. Worried about sloppiness or carelessness
  11. Feeling easily annoyed or irritable
  12. Pains in heart or chest
  13. Itching
  14. Feeling low in energy or slowed down
  15. Thoughts of ending your life
  16. Sweating
  17. Trembling
  18. Feeling confused
  19. Poor appetite
  20. Crying easily
  21. Feeling shy or uneasy with the opposite sex
  22. A feeling of being trapped or caught
  23. Suddenly scared for no reason
  24. Temper outbursts you could not control
  25. Constipation
  26. Blaming yourself for things
  27. Pains in the lower part of your back
  28. Feeling blocked or stymied in getting things done
  29. Feeling lonely
  30. Feeling blue
  31. Worrying or stewing about things
  32. Feeling no interest in things
  33. Feeling fearful
  34. Your feelings being easily hurt
  35. ha‎ving to ask others what you should do
  36. Feeling others do not understand you or are unsympathetic
  37. Feeling that people are unfriendly or dislike you
  38. ha‎ving to do things very slowly in order to be sure you are doing them right
  39. Heart pounding or racing
  40. Nausea or upset stomach
  41. Feeling inferior to others
  42. Soreness of your muscles
  43. Loose bowel movements
  44. Difficulty falling asleep or staying asleep
  45. ha‎ving to check and double check what you do
  46. Difficulty making decisions
  47. Wanting to be alone
  48. Trouble getting your breath
  49. Hot or cold spells
  50. ha‎ving to avoid certain places or activities because they frighten you
  51. Your mind going blank
  52. Numbness or tingling in parts of your body
  53. A lump in your throat
  54. Feeling hopeless about the future
  55. Trouble concentrating
  56. Weakness in parts of your body
  57. Feeling tense or keyed up
  58. Heavy feelings in your arms or legs
★

Rate This Scale

5.0 / 5 • 1 vote

Cite This Article

Looti, M. (2026, September 26). Hopkins Symptom Checklist (HSCL-58). PSYCHOLOGICAL DATABASE. https://english.arabpsychology.com/scales/hopkins-symptom-checklist-hscl-58/
Looti, Mohammed. “Hopkins Symptom Checklist (HSCL-58).” PSYCHOLOGICAL DATABASE, 26 September 2026, https://english.arabpsychology.com/scales/hopkins-symptom-checklist-hscl-58/.
Looti, Mohammed. “Hopkins Symptom Checklist (HSCL-58).” PSYCHOLOGICAL DATABASE. September 26, 2026. https://english.arabpsychology.com/scales/hopkins-symptom-checklist-hscl-58/.